Table 2.

Kaplan–Meier estimation of the cumulative incidence of clinical relapse (CIR, %).

Factor	Cumulative incidence of relapse (CIR) for clinical relapse				p-value
	24 months	48 months	72 months	120 months
Group A (n = 10)	40.0	50.0	70.0	85.0	0.04
Group B (n = 28)	17.2	27.7	33.2	66.6
Cyclophosphamide (n = 5)	0.0	33.3	33.3		0.81
Rituximab (n = 23)	21.1	27.2	33.8	66.9